Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
about
Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemicStatins and its hepatic effects: Newer data, implications, and changing recommendationsNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsNon-Alcoholic Steatohepatitis: Limited Available Treatment Options but Promising Drugs in Development and Recent Progress Towards a Regulatory Approval PathwayTreatment of nonalcoholic steatohepatitis in adults: present and futureNon-alcoholic fatty liver disease.Overview and recent trends of systematic reviews and meta-analyses in hepatology.The Effects of Melatonin on Elevated Liver Enzymes during Statin Treatment.Multimorbidity and polypharmacy in diabetic patients with NAFLD: Implications for disease severity and management.Ananas comosus L. Leaf Phenols and p-Coumaric Acid Regulate Liver Fat Metabolism by Upregulating CPT-1 Expression.Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice.Fimasartan Ameliorates Nonalcoholic Fatty Liver Disease through PPARδ Regulation in Hyperlipidemic and Hypertensive Conditions.NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs.Pleiotropic effects of statins: new therapeutic targets in drug design.Reducing liver function tests for statin monitoring: an observational comparison of two clinical commissioning groups.Rationale for the use of statins in liver disease.Low simvastatin concentrations reduce oleic acid-induced steatosis in HepG2 cells: An in vitro model of non-alcoholic fatty liver disease.Therapeutic effect of rosuvastatin and propylthiouracil on ameliorating high-cholesterol diet-induced fatty liver disease, fibrosis and inflammation in rabbit.Non-alcoholic Fatty Liver Disease: A Clinical Update.Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial.The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.Statins and New-Onset Diabetes in Cardiovascular and Kidney Disease Cohorts: A Meta-Analysis.Evaluation of Statin Treatment for Nonalcoholic Fatty Liver Disease.Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD.
P2860
Q24563381-F1D87781-5FA1-4803-8329-EF8244189B15Q26767065-ED91DDB4-8CEA-4101-9F83-39E0940D17F8Q26796448-D4492D84-82C4-4C76-89B2-37E9B2FC47ADQ26800894-D37AC1FC-7F8F-4F48-9DF5-6A28F439BCB1Q26852403-618908C8-2DE9-42AE-AFA1-5E7978E92A45Q30430392-8AE1044D-290C-4B28-BA30-5CF6FBF5C659Q30434752-98BD2539-D07A-47A2-A1D8-2203B78CD2B2Q33786661-4F62B9BA-5005-487F-AEB6-75DE3E1FF3A6Q33879548-397917CB-15C6-4DA5-A7BB-BD2FF9705C8BQ34093727-84B0C8E0-C875-4353-A8E0-DAA77339125EQ37348597-F40499A8-123F-4BF8-8D5B-08DB29D11282Q37721436-84426732-02AA-46C1-A8B0-845AB699AE4DQ38791719-5BBBE7FA-FEB2-4348-AC54-DE225FCC1653Q38825843-B5164CCA-87DA-4967-A31C-F120F97A9FC5Q38991225-AF285901-220C-418A-BB49-3F48E5E03B73Q39171942-C6336EE4-13D3-40E8-A3F1-18530CB43871Q39646058-E6D356D2-C866-4D4D-9370-DF74B342BB2AQ41549432-91DDDBC1-AEE6-4F6C-8E19-6CC10140A3B2Q47100244-40B68425-351F-4867-BBAC-D4F7249757BFQ47868469-CE08EE61-1640-4457-8B4A-25BE48482D9BQ48152092-C83350FB-856F-4798-8304-31F02D8F32F4Q52607836-297B2ED6-49D5-476E-A39E-3D462C1B52CDQ55265845-625A1E80-5225-4F47-868B-E2E31912D083Q55333527-055FEF8F-A965-41E1-9B97-0EE3B53BD475
P2860
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@ast
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@en
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@en-gb
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@nl
type
label
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@ast
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@en
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@en-gb
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@nl
prefLabel
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@ast
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@en
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@en-gb
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@nl
P2093
P2860
P3181
P1476
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
@en
P2093
Hermineh Aramin
Layli Eslami
Shahin Merat
P2860
P3181
P356
10.1002/14651858.CD008623.PUB2
P577
2013-12-27T00:00:00Z